173 related articles for article (PubMed ID: 26147471)
1. Minimal Prolongation of Prothrombin Time with Extended Exposure to Argatroban.
McAlister RK; Ito S
Pharmacotherapy; 2015 Jul; 35(7):e122-6. PubMed ID: 26147471
[TBL] [Abstract][Full Text] [Related]
2. Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
Bartholomew JR; Hursting MJ
J Thromb Thrombolysis; 2005 Jun; 19(3):183-8. PubMed ID: 16082605
[TBL] [Abstract][Full Text] [Related]
3. Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.
Hursting MJ; Lewis BE; Macfarlane DE
Clin Appl Thromb Hemost; 2005 Jul; 11(3):279-87. PubMed ID: 16015413
[TBL] [Abstract][Full Text] [Related]
4. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
Shapiro NL; Durr EA; Krueger CD
Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
[TBL] [Abstract][Full Text] [Related]
5. Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy.
Austin JH; Stearns CR; Winkler AM; Paciullo CA
Pharmacotherapy; 2012 Jun; 32(6):493-501. PubMed ID: 22511112
[TBL] [Abstract][Full Text] [Related]
6. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
[TBL] [Abstract][Full Text] [Related]
7. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
Burger CF; Schlesinger JJ
Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
[TBL] [Abstract][Full Text] [Related]
8. Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
Nanda MM; Kauflin MJ; Jain PG; Yannetta JC
Ann Pharmacother; 2011 Mar; 45(3):e16. PubMed ID: 21386022
[TBL] [Abstract][Full Text] [Related]
9. Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia.
Vianello F; Furian L; Nordio M; Treleani M; Fabris F
Hematology; 2015 Jan; 20(1):48-9. PubMed ID: 24580134
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use.
Lubenow N; Selleng S; Wollert HG; Eichler P; Müllejans B; Greinacher A
Ann Thorac Surg; 2003 Feb; 75(2):577-9. PubMed ID: 12607680
[TBL] [Abstract][Full Text] [Related]
11. Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin.
Arpino PA; Demirjian Z; Van Cott EM
Pharmacotherapy; 2005 Feb; 25(2):157-64. PubMed ID: 15767231
[TBL] [Abstract][Full Text] [Related]
12. Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
Athar U; Husain J; Hudson J; Lynch J; Gajra A
Am J Hematol; 2008 Mar; 83(3):245-6. PubMed ID: 17910040
[TBL] [Abstract][Full Text] [Related]
13. Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin.
Sheth SB; DiCicco RA; Hursting MJ; Montague T; Jorkasky DK
Thromb Haemost; 2001 Mar; 85(3):435-40. PubMed ID: 11307810
[TBL] [Abstract][Full Text] [Related]
14. Argatroban in adult extracorporeal membrane oxygenation.
Johnston N; Wait M; Huber L
J Extra Corpor Technol; 2002 Dec; 34(4):281-4. PubMed ID: 12533066
[TBL] [Abstract][Full Text] [Related]
15. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Dager WE; White RH
Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
[TBL] [Abstract][Full Text] [Related]
16. Argatroban therapy for heparin-induced thrombocytopenia in acutely ill patients.
Gray A; Wallis DE; Hursting MJ; Katz E; Lewis BE
Clin Appl Thromb Hemost; 2007 Oct; 13(4):353-61. PubMed ID: 17911186
[TBL] [Abstract][Full Text] [Related]
17. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
Demma LJ; Paciullo CA; Levy JH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1213-8. PubMed ID: 22329977
[TBL] [Abstract][Full Text] [Related]
18. Warfarin initiation and monitoring with clotting factors II, VII, and X.
Trask AS; Gosselin RC; Diaz JA; Dager WE
Ann Pharmacother; 2004 Feb; 38(2):251-6. PubMed ID: 14742761
[TBL] [Abstract][Full Text] [Related]
19. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
Hellwig TR; Peitz GJ; Gulseth MP
Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479
[TBL] [Abstract][Full Text] [Related]
20. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
